argenx SE ARGX 深 滬
等待開盤 11-04 09:30:00 美东时间
901.12
+26.150
+2.99%
華盛通- 最 高903.2705
- 今 開874.09
- 成交量 43.22万股
- 最 低 873.32
- 昨 收 874.97
- 總市值 566.68亿
- 52周最高 1072.75
- 市盈率 靜 45.91
- 換手率 0.69%
- 52周最低 661.85
- 委 比 94.71%
- 總股本 6288.61万
- 歷史最高 1072.75
- 量 比 1.53
- 振 幅 3.42%
- 歷史最低 19.00
- 每 手 1
- 風險率 79.50%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅94.81%！富瑞上调ArriVent BioPharma(AVBP)目标价至30美元，维持"买入"评级
今日重点评级关注：富瑞：维持ArriVent BioPharma"买入"评级，目标价从18美元升至30美元；古根海姆：维持第一太阳能"买入"评级，目标价从282美元升至299美元
10-28 12:30
Citigroup Maintains Buy on argenx, Lowers Price Target to $1232
Citigroup analyst Samantha Semenkow maintains argenx (NASDAQ:ARGX) with a Buy and lowers the price target from $1301 to $1232.
10-28 04:19
argenx Q3 EPS $7.80 Misses $7.83 Estimate, Sales $1.751B Beat $1.664B Estimate
argenx (NASDAQ:ARGX) reported quarterly earnings of $7.80 per share which missed the analyst consensus estimate of $7.83 by 0.38 percent. This is a 50.58 percent increase over earnings of $5.18 per share from the same period last year. The company reported quarterly sales of $1.751 billion which bea...
10-22 13:22
美股大行评级 | 潜在涨幅203.03%！BTIG上调Rapport Therapeutics目标价至89美元，维持"买入"评级
今日重点评级关注：BTIG：维持Rapport Therapeutics"买入"评级，目标价从75美元升至89美元；摩根士丹利：维持希捷科技"超配"评级，目标价从1187美元升至1200美元
10-21 12:30
RBC Capital Maintains Outperform on argenx, Lowers Price Target to $1025
RBC Capital analyst Luca Issi maintains argenx (NASDAQ:ARGX) with a Outperform and lowers the price target from $1100 to $1025.
10-20 21:37
argenx SE(ARGX)股票10月20日盘中上涨5.99%：释放什么信号？
• VYVGART Hytrulo 的 ALKIVIA 3 期临床试验取得积极结果，提振了股价。 • 尽管针对次要适应症调整了目标价，分析师仍重申了积极评级。 • Argenx 报告全年营收为 41.5 亿美元，净利润为 12.9 亿美元。
10-20 15:16
argenx SE Stock (ARGX) Moved Up by 5.99% on Oct 20: What Signal Does It Send?
• Positive Phase 3 ALKIVIA trial results for VYVGART Hytrulo boosted shares. • Analysts reaffirmed positive ratings despite price target adjustments for secondary indications. • Argenx reports annual revenue of $4.15B and net profit of $1.29B.
10-20 15:15
美股大行评级 | 潜在涨幅91.5%！巴克莱上调Vertical Aerospace评级至"标配"，目标价下调至1美元
今日重点评级关注：巴克莱：上调Vertical Aerospace评级至"标配"，目标价从2美元降至1美元；巴克莱：维持Bitdeer Technologies"超配"评级，目标价从15美元升至17美元
10-12 14:52
Baird Maintains Neutral on argenx, Lowers Price Target to $823
Baird analyst Colleen Kusy maintains argenx (NASDAQ:ARGX) with a Neutral and lowers the price target from $932 to $823.
10-09 21:29
$100 Invested In argenx 5 Years Ago Would Be Worth This Much Today
argenx (NASDAQ:ARGX) has outperformed the market over the past 5 years by 10.42% on an annualized basis producing an average annual return of 22.71%. Currently, argenx has a market capitalization of $58.39 billion. Buying $100 In ARGX: If an investor had bought $100 of ARGX stock 5 years ago, it wou...
10-09 06:45
